Zynga, Inc. (ZNGA) had a active trading with around 17.3M shares changing hands compared to its three month average trading volume of 13.11M. The stock traded between $2.94 and $3.04 before closing at the price of $3.01 with 2.38% change on the day. The San Francisco California 94103 based company is currently trading 69.1% above its 52 week low of $1.78 and -0.33% below its 52 week high of $3.04. Both the RSI indicator and target price of 63.52 and $3.17 respectively, lead us to believe that it should be put on hold over the coming weeks.
Zynga Inc. develops, markets, and operates social games as live services played on the Internet, social networking sites, and mobile platforms in the United States, North America, Asia, and the European Union. It offers its online social games primarily under the Slots, Words With Friends, Zynga Poker, and FarmVille franchises. The companys games are accessible on mobile platforms, Facebook, and other social networks, as well as Zynga.com. It also provides advertising services to advertising agencies and brokers. The company was formerly known as Zynga Game Network Inc. and changed its name to Zynga Inc. in November 2010. Zynga Inc. was founded in 2007 and is headquartered in San Francisco, California.
Pfizer Inc. (PFE) managed to rebound with the stock climbing 0.15% or $0.05 to close the day at $33.61 on light trading volume of 16.33M shares, compared to its three month average trading volume of 18.87M. The New York New York 10017 based company has been outperforming the drug manufacturers – major group over the past 52 weeks, with the stock gaining 4.74%, compared to the industry which has advanced 6.06% over the same period. With RSI of 42.8, the stock should still continue to rise and get closer to its one year target estimate of $39.4, making it a hold for now.
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells healthcare products worldwide. The company operates through Global Innovative Pharmaceutical (GIP); Global Vaccines, Oncology and Consumer Healthcare (VOC); and Global Established Pharmaceutical (GEP) segments. The GIP segment develops and commercializes medicines for various therapeutic areas, including inflammation/immunology, cardiovascular/metabolic, neuroscience/pain, and rare diseases. The VOC segment develops and commercializes vaccines, as well as products for oncology and consumer healthcare. It provides over-the-counter products comprising dietary supplements under the Centrum, Caltrate, and Emergen-C brands; pain management products under the Advil and ThermaCare brands; gastrointestinal products under the Nexium 24HR/Nexium Control and Preparation H brands; and respiratory and personal care products under the brand names of Robitussin, Advil Cold & Sinus, Advil Sinus Congestion Relief & Pain, Dimetapp, and ChapStick. The GEP segment offers products that have lost marketing exclusivity in various markets; and branded generics, generic sterile injectable products, biosimilars, infusion systems, and other products. The company serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as centers for disease control and prevention. It has licensing agreements with Cellectis SA and AstraZeneca PLC; and collaborative agreements with Eli Lilly & Company, OPKO Health, Inc., BioRap Technologies LTD., and Merck KGaA. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Cosi Inc. (COSI) shares were down in last trading by -24.4% to $0.03. It experienced higher than average volume on day. The stock decreased in value by almost -60.08% over the past week and fell -84.41% in the past month. It is currently trading -85.43% below its 50 day moving average and -94.23% below its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -97.29% decrease in value from its one year high of $1.05. The RSI indicator value of 26.81, lead us to believe that it may correct downwards in the near term.
Cosi, Inc. owns, operates, and franchises fast-casual restaurants. The company offers food and beverage products for four dayparts comprising breakfast, lunch, snacking, and dinner. It also provides catering services for breakfast, lunch, afternoon snacking, and special events. As of December 28, 2015, the company operated 79 company-owned and 31 franchise restaurants in 15 states, the District of Columbia, the United Arab Emirates, and Costa Rica. Cosi, Inc. was founded in 1994 and is headquartered in Boston, Massachusetts. On September 28, 2016, Cosi, Inc., along with its 4 affiliates, filed a voluntary petition for reorganization under Chapter 11 in the US Bankruptcy Court for the District of Massachusetts.